Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion type Assertion NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_head.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion description "[The risk of brain tumors was significantly higher (2.5%) in MSH2 gene mutation carriers compared to patients with mutations in MLH1 or MSH6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_provenance.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion evidence source_evidence_literature NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_provenance.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion SIO_000772 25648859 NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_provenance.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion wasDerivedFrom befree-2016 NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_provenance.
- NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_assertion wasGeneratedBy ECO_0000203 NP1260813.RAJv9XTGr5x3NGdD3oFkGDQjrc88I6Bl6_60BcCHg5VSE130_provenance.